Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie Partyka

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Proteomics|July 14, 2011
Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseasesTingting Yue, Katie Partyka, Kevin A Maupin, et al.
Scientific Reports|June 24, 2017
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer CellsDaniel Barnett, Ying Liu, Katie Partyka, et al.
Plos One|December 20, 2016
A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the PancreasJessica Sinha, Zheng Cao, Jianliang Dai, et al.
Molecular & Cellular Proteomics : MCP|March 4, 2015
Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis AHuiyuan Tang, Sudhir Singh, Katie Partyka, et al.
Analytical Chemistry|November 5, 2016
Characterizing Protein Glycosylation through On-Chip Glycan Modification and ProbingBryan S Reatini, Elliot Ensink, Brian Liau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer DiagnosisBen Staal, Ying Liu, Daniel Barnett, et al.
Plos One|January 6, 2012
Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriersTingting Yue, Kevin A Maupin, Brian Fallon, et al.
Journal of Proteome Research|May 5, 2015
Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectinsSudhir Singh, Kuntal Pal, Jessica Yadav, et al.
Plos One|October 3, 2015
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma SpecimensBrian B Haab, Ying Huang, Seetharaman Balasenthil, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proteomics|July 14, 2011
Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseasesTingting Yue, Katie Partyka, Kevin A Maupin, et al.
Scientific Reports|June 24, 2017
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer CellsDaniel Barnett, Ying Liu, Katie Partyka, et al.
Plos One|December 20, 2016
A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the PancreasJessica Sinha, Zheng Cao, Jianliang Dai, et al.
Molecular & Cellular Proteomics : MCP|March 4, 2015
Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis AHuiyuan Tang, Sudhir Singh, Katie Partyka, et al.
Analytical Chemistry|November 5, 2016
Characterizing Protein Glycosylation through On-Chip Glycan Modification and ProbingBryan S Reatini, Elliot Ensink, Brian Liau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer DiagnosisBen Staal, Ying Liu, Daniel Barnett, et al.
Plos One|January 6, 2012
Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriersTingting Yue, Kevin A Maupin, Brian Fallon, et al.
Journal of Proteome Research|May 5, 2015
Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectinsSudhir Singh, Kuntal Pal, Jessica Yadav, et al.
Plos One|October 3, 2015
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma SpecimensBrian B Haab, Ying Huang, Seetharaman Balasenthil, et al.
Pageof 2